Teva Pharma (TEVA) Tops Q1 EPS by 4c, Revenues Miss; Offers FY21 EPS/Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 41.91 +1.21 (2.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.70 | 52 Week High | $66.55 | |||
| Open | $41.91 | 52 Week Low | $37.82 | |||
| Day High | $43.34 | P/E | N/A | |||
| Day Low | $41.54 | EPS | $0.00 | |||
| Volume | 11,671,447 | |||||
